Literature DB >> 3300911

Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels.

B M Altura, B T Altura, A Carella, A Gebrewold, T Murakawa, A Nishio.   

Abstract

Contractility of all types of invertebrate and vertebrate muscle is dependent upon the actions and interactions of two divalent cations, viz, calcium (Ca2+) and magnesium (Mg2+) ions. The data presented and reviewed herein contrast the actions of several organic Ca2+ channel blockers with the natural, physiologic (inorganic) Ca2+ antagonist, Mg2+, on microvascular and macrovascular smooth muscles. Both direct in vivo studies on microscopic arteriolar and venular smooth muscles and in vitro studies on different types of blood vessels are presented. It is clear from the studies done so far that of all Ca2+ antagonists examined, only Mg2+ has the capability to inhibit myogenic, basal, and hormonal-induced vascular tone in all types of vascular smooth muscle. Data obtained with verapamil, nimopidine, nitrendipine, and nisoldipine on the microvasculature are suggestive of the probability that a heterogeneity of Ca2+ channels, and of Ca2+ binding sites, exists in different microvascular smooth muscles; although some appear to be voltage operated and others, receptor operated, they are probably heterogeneous in composition from one vascular region to another. Mg2+ appears to act on voltage-, receptor-, and leak-operated membrane channels in vascular smooth muscle. The organic Ca2+ channel blockers do not have this uniform capability; they demonstrate a selectivity when compared with Mg2+. Mg2+ appears to be a special kind of Ca2+ channel antagonist in vascular smooth muscle. At vascular membranes it can (i) block Ca2+ entry and exit, (ii) lower peripheral and cerebral vascular resistance, (iii) relieve cerebral, coronary, and peripheral vasospasm, and (iv) lower arterial blood pressure. At micromolar concentrations (i.e., 10-100 microM). Mg2+ can cause significant vasodilatation of intact arterioles and venules in all regional vasculatures so far examined. Although Mg2+ is three to five orders of magnitude less potent than the organic Ca2+ channel blockers, it possesses unique and potentially useful Ca2+ antagonistic properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300911     DOI: 10.1139/y87-120

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  44 in total

1.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 2.  Possible pharmacological actions of magnesium in acute myocardial infarction.

Authors:  K L Woods
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

3.  Tuning magnesium sensitivity of BK channels by mutations.

Authors:  Huanghe Yang; Lei Hu; Jingyi Shi; Jianmin Cui
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

4.  Seizures in Women with Preeclampsia: Mechanisms and Management.

Authors:  Marilyn J Cipolla; Richard P Kraig
Journal:  Fetal Matern Med Rev       Date:  2011-05

5.  Cross-sectional associations of medication and supplement use with retinal vascular diameter in the Beaver Dam Eye Study.

Authors:  Kerri P Howard; Barbara E K Klein; Jennifer O Dreyer; Lorraine G Danforth; Ronald Klein
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

6.  Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.

Authors:  P Laurant; A Berthelot
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles.

Authors:  Takahiro Murata; Hans H Dietrich; Tetsuyoshi Horiuchi; Kazuhiro Hongo; Ralph G Dacey
Journal:  Neurosci Res       Date:  2015-12-19       Impact factor: 3.304

8.  Intracellular Mg(2+) enhances the function of BK-type Ca(2+)-activated K(+) channels.

Authors:  J Shi; J Cui
Journal:  J Gen Physiol       Date:  2001-11       Impact factor: 4.086

9.  [The use of magnesium sulfate during surgery of pheochromocytoma: apropos of 2 cases].

Authors:  P Drolet; M Girard
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

Review 10.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.